Coronary Atherectomy Devices Global Market Report 2024

The coronary atherectomy devices market size has grown rapidly in recent years. It will grow from $0.2 billion in 2023 to $0.22 billion in 2024 at a compound annual growth rate (CAGR) of 10.2%. Historical growth in the sector can be ascribed to the increased occurrence of coronary artery disease, amplified interest in minimally invasive procedures, the rising demand for coronary atherectomy devices, and the escalation in disposable incomes.

The coronary atherectomy devices market size is expected to see strong growth in the next few years. It will grow to $0.31 billion in 2028 at a compound annual growth rate (CAGR) of 9.2%. The anticipated growth in the upcoming period is anticipated due to factors such as an aging population, increased adoption of hybrid procedures, augmented industry investments, and growing awareness among patients and physicians. Noteworthy trends anticipated during this period include advancements in coronary atherectomy devices, miniaturization, improved imaging technologies, personalized treatment approaches, enhancements in device design, and the integration of robotics and artificial intelligence.

The growing incidence of cardiovascular diseases (CVDs) has led to a heightened demand for atherectomy devices in the treatment of CVDs. This surge in CVD cases can be attributed to factors such as smoking, physical inactivity, and unhealthy dietary habits. As of September 2023, the Center for Disease Control and Prevention reported that the United States recorded 695,547 deaths attributed to cardiovascular diseases in 2021. Furthermore, the American College of Cardiology, in its August 2022 findings, predicted a 30.7% increase in risk factors for ischemic heart disease, projecting a total of 29 million cases by 2025. Consequently, the escalating prevalence of cardiovascular diseases is anticipated to be a driving force behind the global coronary atherectomy devices market's growth.

The primary products in coronary atherectomy devices include directional atherectomy devices, orbital atherectomy devices, photo-ablative atherectomy devices, rotational atherectomy devices, among others. Rotational atherectomy devices, for instance, consist of a lengthy catheter housing a microscopic diamond-embedded, oval-shaped burr for the purpose of effectively addressing coronary conditions. These devices are widely utilized across various applications such as peripheral vascular, cardiovascular, and neurovascular treatments. They are employed by a range of end-users, including hospitals, surgical centers, ambulatory care facilities, research laboratories, and academic institutes.

The coronary atherectomy devices market research report is one of a series of new reports that provides coronary atherectomy devices market statistics, including coronary atherectomy devices industry global market size, regional shares, competitors with a coronary atherectomy devices market share, detailed coronary atherectomy devices market segments, market trends and opportunities, and any further data you may need to thrive in the coronary atherectomy devices industry. This coronary atherectomy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Increasing healthcare spending is poised to fuel the expansion of the seborrheic dermatitis market. Healthcare expenditure constitutes the overall costs invested in healthcare-related products and services within a specific healthcare system or economy. This investment plays a vital role in fostering the development, accessibility, and utilization of seborrheic dermatitis treatments. For instance, as per the November 2022 report by the Canadian Institute for Health Information, healthcare spending surged to $331 billion, a rise of 0.8% from the previous year's 7.6% in 2021. Hence, the upward trajectory of healthcare expenditure is a significant driver behind the growth of the seborrheic dermatitis market.

In the forecast period, the prolonged medical device approval procedures are anticipated to impede the expansion of the coronary atherectomy devices market. Regulatory authorities have enforced stringent regulations concerning labeling, pre-market approval, medical device reporting, and product launches. These devices are categorized as Class II, indicating a higher level of risk. Consequently, rigorous government regulations have the potential to hinder the growth of the coronary atherectomy devices market.

Prominent manufacturers in the coronary atherectomy equipment market are proactively engaging in strategic partnerships and collaborations with start-ups and mid-sized companies to diversify their product and service offerings. For example, in 2021, Cardiovascular Systems, Inc. revealed the acquisition of peripheral support catheters from Wavepoint Medical LLC for an undisclosed sum. This acquisition, benefiting Cardiovascular Systems, Inc., headquartered in St. Paul, Minnesota, a medical device company specializing in the development and commercialization of innovative solutions for treating vascular and coronary diseases.

Prominent companies in the coronary atherectomy devices market are intensifying their efforts to introduce cutting-edge devices like orbital atherectomy systems, aiming to secure a competitive advantage in the market. The orbital atherectomy system serves as a medical device dedicated to addressing calcified plaque in both coronary and peripheral arteries. Distinguished by its distinct mode of action, the system is employed for preparing calcified plaque lesions prior to percutaneous coronary intervention (PCI) and treating peripheral artery disease (PAD). As an example, in October 2022, Cardiovascular Systems, Inc., a US-based medical device company, unveiled the Peripheral Orbital Atherectomy Systems 2.00 Max Crown. This innovative device incorporates a larger 70-micron diamond-coated crown, enhancing its effectiveness in engaging mixed plaque and ensuring superior outcomes. Particularly for individuals with peripheral artery disease, the Diamondback 360 Peripheral Orbital Atherectomy System offers discreet minimally invasive treatment options.

In April 2023, Abbott Laboratories, a US-based medical device firm, finalized the acquisition of Cardiovascular Systems, Inc. for $890 million. Through this acquisition, Abbott aims to enhance their capacity to cater to patients dealing with peripheral and coronary artery disease, particularly by preparing the arteries for angioplasty or stenting procedures to restore adequate blood flow. Cardiovascular Systems, Inc., a US-based medical device company, specializes in developing advanced treatments for coronary artery disease and challenging peripheral vascular conditions.

Major companies operating in the coronary atherectomy devices market include Boston Scientific Corporation, Koninklijke Philips N.V., Cardiovascular Systems Inc., The Spectranetics Corporation, Medtronic Inc., Avinger Inc., Biotronik SE & Co KG, Arterial Remodeling Technologies, Atrium Medical Corporation, B. Braun Melsungen AG, Balton Sp. z o.o., Biosensors International Group Ltd., Straub Medical AG, C.R. Bard Inc., RA Medical Systems Inc., Shockwave Medical Inc., Terumo Corporation, Abbott Laboratories Inc., Asahi Intecc Co. Ltd., Baylis Medical Company Inc., Cook Medical LLC, Cordis Corporation, Edwards Lifesciences Corporation, Endologix Inc., Infraredx Inc., Intact Vascular Inc., Lutonix Inc., Mercator MedSystems Inc., Miracor Medical Systems GmbH, OrbusNeich Medical Company Limited, QT Vascular Ltd., TriReme Medical LLC, Vascular Solutions Inc., Volcano Corporation

North America was the largest region in the coronary atherectomy devices market in 2023. Western Europe was the second-largest region in the global coronary atherectomy devices market share. Africa, was the smallest region in the coronary atherectomy devices industry. The regions covered in the coronary atherectomy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the coronary atherectomy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The coronary atherectomy devices market consists of sales of directional atherectomy devices, orbital atherectomy devices, photo-ablative atherectomy devices, rotational atherectomy devices, and others that are used to treat coronary atherectomy. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.